Black Forest Biologicals, a biotech startup, has a promising Alzheimer's drug candidate Compound SLT-88 entering Phase 1 trials this year. SLT-88 is the only product formed by the reaction of two precursor compounds A and B, both of which are quite expensive. The chief medicinal chemist of Black Forest is trying out different reaction conditions to minimize the cost of manufacturing SLT-88. In the table below are listed the initial and final amounts of A and B used under two different trial conditions, and also the actual amount of SLT-88 recovered in each case. Complete the table by calculating the theoretical yield of SLT-88 and the percent yield of SLT-88. Round your amounts to the nearest milligram and your percentages to the nearest whole percent. Trial 1 2 amount of A initial final amount of B initial 350 mg 0 mg 350 mg final 175. mg 750. mg 0 mg 950, mg 665. mg yield of SLT-88 theoretical 0 0 actual 357. mg 549. mg % 0% 0% 0.P D.D DO G

Predict the products of the reaction.

Foreattt part of iTIS qtestfoni; tonsider FOHOWIHg Btetat: You need to make a stock solution of Ca( C2H3O2 )2 with a concentration of 6.50 M. You have a 850.0 mL volumetric flask available to make this stock solution in. You are then tasked with using this stock solution to prepare a sample for use in an experiment. The experimental sample should have a final volume of 15.0 mL and a concentration of 0.350 M Ca(C2H3O2)2. a) What is the molar mass of Ca(C2H3O2)2? b) How many moles of the solute would be needed to create the stock solution using the volumetric flask available? c) How many grams of the solute should be added to the volumetric flask to create the stock solution? d) What volume, in mL, of the stock solution should be used to prepare the experimental solution through dilution? US 目 M